Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • JornBR
    Junior Member
    • Mar 2017
    • 2

    #1

    Assembly

    HI Im new in NGS and I have a maybe silly question, I sequenced two isolates of my bacteria of interest and the genome of the reference strain is complete and available. I wonder if it is best to assemble against the reference genome or make a de novo assembly so I don't lose information that maybe is not present in the reference.

    Hope someone can help me to take the right option.
  • mastal
    Senior Member
    • Mar 2009
    • 666

    #2
    If there is a reference genome available, then you can do a reference guided assembly in the first instance.

    Bacterial genomes are not very large, so shouldn't require too much in the way of computational resources, so you can try both methods and compare the results.

    Comment

    • Brian Bushnell
      Super Moderator
      • Jan 2014
      • 2709

      #3
      I would encourage you to do a completely de novo assembly. As mastal said, you can easily do this both ways and compare results. But, a purely de novo assembly has less risk of mistakes due to differences from the reference. You can obviously gain more continuity with a reference-guided approach, but you will incur misassemblies, so I don't think it's a good idea.

      Comment

      • gringer
        David Eccles (gringer)
        • May 2011
        • 845

        #4
        What platform did you do the bacterial sequencing on? Why do you need to assemble at all (rather than just looking for variants that differ from the reference)?

        If a full-length assembly is absolutely required, do you have another $2000 USD to resequence those isolates (and another 10 more) on a rapid barcoded run of a MinION?

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        13 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        32 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        40 views
        0 reactions
        Last Post SEQadmin2  
        Working...